Current Affairs - National - Discussion

Discussion Forum : National - Latest Current Affairs (Q.No. 5103)
5103.
Which company launched its generic version of cancer drug Dasatinib in India?
Cipla
Shilpa Medicare
Sun Pharmaceutical
Divi's Laboratories
Answer: Option
Explanation:
Shilpa Medicare launched its generic version of cancer drug Dasatinib. The monthly therapy cost of Rs.6,440. The company launched the Indian branded generic of Dasatinib, an anti-cancer drug with a brand name "Dasashil". Dasashil, the branded generic anti-cancer drug, will be available in all dosage strengths of 20 mg, 50 mg, 70 mg, and 100 mg tablets.
Discussion:
Be the first person to comment on this question !

Post your comments here:

Your comments will be displayed after verification.